BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 9, 2011
View Archived Issues
New epigenetic therapy for aggressive leukemia shows promise in vivo
Read More
Novel target and agents explored for treating hypertension
Read More
Presentations provide further phase II data on lesinurad in gout
Read More
Abatacept shows efficacy in subgroup of patients with lupus nephritis
Read More
New beta-secretase 1 inhibitors disclosed by Array BioPharma and Genentech
Read More
GLCCI1 gene variants linked to response to inhaled glucocorticoid asthma therapy
Read More
Novel kinesin-like protein KIF11 inhibitors presented
Read More
Scientists present new MAP kinase p38 inhibitors
Read More
Dainippon Sumitomo Pharma reviews activities of second quarter of fiscal year 2011
Read More
University of North Carolina team patents novel anisamide-oligonucleotide conjugates
Read More
LivTech and Yakult Honsha enter option agreement for LIV-2008 anticancer program
Read More
Gilead Sciences and the Cardiovascular Research Foundation start new ranolazine trial
Read More
Novel vaccines for human cytomegalovirus infection prepared in Germany
Read More
Taisho Pharmaceutical recaps events of second quarter of fiscal year 2011
Read More
Corimmun discloses new fusion proteins for cardiovascular diseases
Read More
NeurogesX reports encouraging results on NGX-1998 in postherpetic neuralgia
Read More
EC grants marketing authorization to orphan drug for adrenal insufficiency in adults
Read More
Lilly and Amylin reach agreement to terminate diabetes alliance
Read More
Ablynx and Merck Serono enter new Nanobodies collaboration
Read More
Salix Pharmaceuticals to acquire Oceana Therapeutics
Read More
FDA approves Erbitux for new indication
Read More
FDA accepts NDA for vismodegib
Read More
Gen-Probe files notice relating to FDA review of Progensa PCA3 assay
Read More
Opexa Therapeutics' lead product receives FDA fast track status
Read More
BARDA awards contract to RxBio to develop radiomitigant countermeasure drug
Read More
